<DOC>
	<DOCNO>NCT00388999</DOCNO>
	<brief_summary>MBL deficient patient enrol protocol schedule treat melphalan-based high-dose chemotherapy follow autologous hematopoietic stem cell transplant ( HSCT ) multiple myeloma . Patients randomize 0.5 mg/kg , 1.0 mg/kg , rhMBL .</brief_summary>
	<brief_title>Intravenous rhMBL Patients With Multiple Myeloma Receiving Chemotherapy Followed Stem Cell Transplant</brief_title>
	<detailed_description>MBL deficient patient randomize ratio 2:2:1 receive 4 weekly i.v . infusion rhMBL dose 0.5 mg/kg 1.0 mg/kg , standard anti-infectious prophylactic therapy alone . A total 20 patient treated rhMBL arm , 10 patient receive best standard supportive prophylactic therapy rhMBL . All patient receive anti-infectious prophylactic supportive therapy per institutional standard .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Major Patients must meet follow criterion eligible enrollment study : Capable understanding protocol requirement risk provide write informed consent . Histologically cytologically confirm diagnosis multiple myeloma . Mannosebinding lectin level &lt; 300 ng/mL . Age â‰¥18 year old . Score 0 2 Zubrod performance status scale . Patient schedule receive melphalanbased highdose chemotherapy autologous HSCT treatment multiple myeloma . Concurrent serious medical illness could potentially interfere protocol compliance . Concurrent previous malignancy associate poor prognosis . Known chronic infectious disease , acquire immunodeficiency syndrome ( AIDS ) hepatitis ( hepatitis human immunodeficiency virus [ HIV ] perform ) . Positive screening pregnancy test breastfeeding . Female male patient reproductive capacity unwilling use method appropriate prevent pregnancy course protocol . Known clinically suspect active brain metastasis . Current participation another clinical study investigational agent and/or use investigational drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Stem Cell Transplant</keyword>
	<keyword>rhMBL</keyword>
</DOC>